Abstract
Comparative molecular field analysis (CoMFA) is a widely used 3D-QSAR method by which we can investigate the potential relation between biological activity of compounds and their structural features. In this study, a new application of this approach is presented by combining the molecular modeling with a new developed pharmacophore model specific to CYP1A2 active site. During constructing the model, we used the molecular dynamics simulation and molecular docking method to select the sensible binding conformations for 17 CYP1A2 substrates based on the experimental data. Subsequently, the results obtained via the alignment of binding conformations of substrates were projected onto the active- site residues, upon which a simple blueprint of active site was produced. It was validated by the experimental and computational results that the model did exhibit the high degree of rationality and provide useful insights into the substrate binding. It is anticipated that our approach can be extended to investigate the protein-ligand interactions for many other enzyme-catalyzed systems as well.
Keywords: CYP1A2, substrate binding, pharmocophore model, CoMFA, MD simulation, molecular docking, 3D-QSAR, enzyme, monooxygenase
Medicinal Chemistry
Title:A Pharmacophore Model Specific to Active Site of CYP1A2 with a Novel Molecular Modeling Explorer and CoMFA
Volume: 8 Issue: 2
Author(s): Hitesh K. Agarwal, Gustavo F. Doncel, Keykavous Parang
Affiliation:
Keywords: CYP1A2, substrate binding, pharmocophore model, CoMFA, MD simulation, molecular docking, 3D-QSAR, enzyme, monooxygenase
Abstract: Comparative molecular field analysis (CoMFA) is a widely used 3D-QSAR method by which we can investigate the potential relation between biological activity of compounds and their structural features. In this study, a new application of this approach is presented by combining the molecular modeling with a new developed pharmacophore model specific to CYP1A2 active site. During constructing the model, we used the molecular dynamics simulation and molecular docking method to select the sensible binding conformations for 17 CYP1A2 substrates based on the experimental data. Subsequently, the results obtained via the alignment of binding conformations of substrates were projected onto the active- site residues, upon which a simple blueprint of active site was produced. It was validated by the experimental and computational results that the model did exhibit the high degree of rationality and provide useful insights into the substrate binding. It is anticipated that our approach can be extended to investigate the protein-ligand interactions for many other enzyme-catalyzed systems as well.
Export Options
About this article
Cite this article as:
Hitesh K. Agarwal, Gustavo F. Doncel, Keykavous Parang , A Pharmacophore Model Specific to Active Site of CYP1A2 with a Novel Molecular Modeling Explorer and CoMFA , Medicinal Chemistry 2012; 8 (2) . https://dx.doi.org/10.2174/157340612800493601
DOI https://dx.doi.org/10.2174/157340612800493601 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Physiology and Pharmacology of the Vanilloid Receptor
Current Neuropharmacology A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease
Current Medicinal Chemistry Adenosine Receptors: What We Know and What We are Learning
Current Topics in Medicinal Chemistry Novel Therapeutic Approaches in Limiting Oxidative Stress and Inflammation
Current Pharmaceutical Biotechnology Dietary Intake in HIV-Infected Men with Lipodystrophy: Relationships with Body Composition, Visceral Fat, Lipid, Glucose and Adipokine Metabolism
Current HIV Research Pharmacogenetic Applications of the Post Genomic Era
Current Pharmaceutical Biotechnology Dietary Compounds, Epigenetic Modifications and Metabolic Diseases
Current Chemical Biology Alzheimer Disease and Diabetes Mellitus: Do They have Anything in Common?
Current Alzheimer Research Phosphodiesterase Type 5 Inhibitors: Unmet Needs
Current Pharmaceutical Design Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Mannose Binding Lectin: A Potential Biomarker for Many Human Diseases
Current Medicinal Chemistry The Innate Immune System and Fever under Redox Control: A Narrative Review
Current Medicinal Chemistry Understanding of and Possible Strategies to Avian Influenza Outbreak
Current Pharmaceutical Biotechnology Protease Inhibitors in the Clinic
Medicinal Chemistry S1P Regulation of Macrophage Functions in the Context of Cancer
Anti-Cancer Agents in Medicinal Chemistry Phytochemicals and Antioxidants: An Evaluation in Understanding the Human Lifeline
Current Nutrition & Food Science The Quest for Novel Biomarkers in Early Diagnosis of Diabetic Neuropathy
Current Proteomics Status of Herbal Medicines in the Treatment of Diabetes: A Review
Current Diabetes Reviews Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications
Current Pharmaceutical Design Vasculitis Beyond the Kidneys
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued)